Fairfield, Bush & Co’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Fairfield, Bush & Co's IBB Position: Q3 2026 in Review
Fairfield, Bush & Co increased its iShares Biotechnology ETF (IBB) stake by 2.5% in Q3 2026, buying an estimated $6.02K and bringing the position to 1,253 shares worth $264K. The position accounts for 0.12% of the portfolio, ranked #112.
Fairfield, Bush & Co first reported a position in IBB in Q2 2022 and has held it in 6 quarters since. 957 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Fairfield, Bush & Co held 1,253 shares of iShares Biotechnology ETF worth $264K as of Q3 2026.
- Fairfield, Bush & Co bought 30 iShares Biotechnology ETF shares in Q3 2026, an estimated $6.02K.
- iShares Biotechnology ETF made up 0.12% of Fairfield, Bush & Co's portfolio in Q3 2026, its #112 holding.
- Fairfield, Bush & Co first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 6 quarters since.
- 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Fairfield, Bush & Co's 13F filing for Q3 2026, filed 13 Nov 2026.